Silence Therapeutics Plc (SLNCF)
4.00
-1.50
(-27.27%)
USD |
OTCM |
Aug 24, 16:00
Silence Therapeutics Total Return Level : 4.00 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.00 |
| August 21, 2026 | 5.50 |
| August 20, 2026 | 5.50 |
| August 19, 2026 | 5.50 |
| August 18, 2026 | 5.50 |
| August 17, 2026 | 5.99 |
| August 14, 2026 | 5.99 |
| August 13, 2026 | 5.99 |
| August 12, 2026 | 5.99 |
| August 11, 2026 | 4.575 |
| August 10, 2026 | 4.50 |
| August 07, 2026 | 1.50 |
| August 06, 2026 | 1.50 |
| August 05, 2026 | 1.50 |
| August 04, 2026 | 1.50 |
| August 03, 2026 | 1.50 |
| July 31, 2026 | 1.50 |
| July 30, 2026 | 1.50 |
| July 29, 2026 | 1.50 |
| July 28, 2026 | 1.50 |
| July 27, 2026 | 1.50 |
| July 24, 2026 | 1.50 |
| July 23, 2026 | 1.50 |
| July 22, 2026 | 1.50 |
| July 21, 2026 | 1.50 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.50 |
| July 17, 2026 | 1.50 |
| July 16, 2026 | 1.50 |
| July 15, 2026 | 1.50 |
| July 14, 2026 | 1.50 |
| July 13, 2026 | 1.50 |
| July 10, 2026 | 1.50 |
| July 09, 2026 | 1.50 |
| July 08, 2026 | 1.50 |
| July 07, 2026 | 1.50 |
| July 06, 2026 | 1.50 |
| July 02, 2026 | 1.50 |
| July 01, 2026 | 2.20 |
| June 30, 2026 | 2.20 |
| June 29, 2026 | 2.20 |
| June 26, 2026 | 2.20 |
| June 25, 2026 | 2.20 |
| June 24, 2026 | 2.20 |
| June 23, 2026 | 2.20 |
| June 22, 2026 | 2.20 |
| June 18, 2026 | 2.21 |
| June 17, 2026 | 2.21 |
| June 16, 2026 | 2.21 |
| June 15, 2026 | 2.21 |
| June 12, 2026 | 1.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Biodexa Pharmaceuticals Plc | 1.20 |
| NuCana Plc | 1.47 |
| Mereo BioPharma Group Plc | 0.2895 |
| Compass Pathways Plc | 14.20 |
| HemoGenyx Pharmaceuticals Plc | 2.33 |